NZ607935A - Pharmaceutical compositions comprising rifaximin - Google Patents
Pharmaceutical compositions comprising rifaximinInfo
- Publication number
- NZ607935A NZ607935A NZ607935A NZ60793511A NZ607935A NZ 607935 A NZ607935 A NZ 607935A NZ 607935 A NZ607935 A NZ 607935A NZ 60793511 A NZ60793511 A NZ 60793511A NZ 607935 A NZ607935 A NZ 607935A
- Authority
- NZ
- New Zealand
- Prior art keywords
- rifaximin
- particles
- micrometres
- polymer
- pharmaceutical composition
- Prior art date
Links
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title abstract 4
- 229960003040 rifaximin Drugs 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000002245 particle Substances 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000006185 dispersion Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000002002 slurry Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
- G01N2013/006—Dissolution of tablets or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2522MU2010 | 2010-09-13 | ||
| IN2539MU2010 | 2010-09-14 | ||
| PCT/GB2011/000785 WO2012035283A1 (en) | 2010-09-13 | 2011-05-23 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ607935A true NZ607935A (en) | 2015-01-30 |
Family
ID=44169144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ607935A NZ607935A (en) | 2010-09-13 | 2011-05-23 | Pharmaceutical compositions comprising rifaximin |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130315988A1 (enExample) |
| EP (1) | EP2616044A1 (enExample) |
| JP (1) | JP2013537182A (enExample) |
| KR (1) | KR20140029356A (enExample) |
| CN (1) | CN103221032A (enExample) |
| AU (1) | AU2011303715A1 (enExample) |
| BR (1) | BR112013005772A2 (enExample) |
| CA (1) | CA2810598A1 (enExample) |
| MX (1) | MX2013002802A (enExample) |
| NZ (1) | NZ607935A (enExample) |
| RU (1) | RU2013113752A (enExample) |
| WO (1) | WO2012035283A1 (enExample) |
| ZA (1) | ZA201301920B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| GB201306980D0 (en) * | 2013-04-17 | 2013-05-29 | Blueberry Therapeutics Ltd | Methods |
| WO2015140569A1 (en) * | 2014-03-20 | 2015-09-24 | Cipla Limited | Pharmaceutical composition |
| AU2015260837B2 (en) | 2014-05-12 | 2019-02-28 | Alfasigma S.P.A. | New solvated crystal form of rifaximin, production, compositions and uses thereof |
| WO2016014437A1 (en) * | 2014-07-21 | 2016-01-28 | Hiroaki Serizawa | Ophthalmic compositions of rifamycins and uses thereof |
| ES2979135T3 (es) | 2016-10-14 | 2024-09-24 | Cipla Ltd | Composiciones farmacéuticas que comprenden rifaximina |
| WO2020219406A1 (en) * | 2019-04-22 | 2020-10-29 | Mylan Specialty L.P. | Meloxicam co-crystal compositions |
| MX427410B (es) | 2019-09-24 | 2025-10-13 | Bausch Health Ireland Ltd | Formulaciones liquidas de rifaximina |
| CA3184054A1 (en) | 2020-06-26 | 2021-12-30 | Jacob Cole | Targeted release rifaximin compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
| IT1290679B1 (it) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| WO2007047253A2 (en) | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| CN100490790C (zh) * | 2007-04-28 | 2009-05-27 | 杭州民生药业集团有限公司 | 一种奥美拉唑肠溶微丸胶囊及其制备方法 |
| JP5755878B2 (ja) * | 2007-07-06 | 2015-07-29 | ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ | リファキシミンの薬剤組成物 |
| JP2009137922A (ja) * | 2007-11-16 | 2009-06-25 | Kaneka Corp | リファマイシン誘導体を傷害組織にデリバリーする製剤 |
| US8486956B2 (en) * | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| US8916193B2 (en) | 2008-12-10 | 2014-12-23 | Cipla Limited | Rifaximin complexes |
-
2011
- 2011-05-23 CN CN201180054627XA patent/CN103221032A/zh active Pending
- 2011-05-23 EP EP11724702.3A patent/EP2616044A1/en not_active Withdrawn
- 2011-05-23 US US13/822,478 patent/US20130315988A1/en not_active Abandoned
- 2011-05-23 RU RU2013113752/15A patent/RU2013113752A/ru not_active Application Discontinuation
- 2011-05-23 BR BR112013005772A patent/BR112013005772A2/pt not_active IP Right Cessation
- 2011-05-23 AU AU2011303715A patent/AU2011303715A1/en not_active Abandoned
- 2011-05-23 NZ NZ607935A patent/NZ607935A/en not_active IP Right Cessation
- 2011-05-23 KR KR1020137007569A patent/KR20140029356A/ko not_active Withdrawn
- 2011-05-23 JP JP2013527670A patent/JP2013537182A/ja not_active Ceased
- 2011-05-23 CA CA2810598A patent/CA2810598A1/en not_active Abandoned
- 2011-05-23 WO PCT/GB2011/000785 patent/WO2012035283A1/en not_active Ceased
- 2011-05-23 MX MX2013002802A patent/MX2013002802A/es not_active Application Discontinuation
-
2013
- 2013-03-12 ZA ZA2013/01920A patent/ZA201301920B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201301920B (en) | 2013-10-30 |
| CN103221032A (zh) | 2013-07-24 |
| RU2013113752A (ru) | 2014-10-20 |
| MX2013002802A (es) | 2013-06-03 |
| WO2012035283A1 (en) | 2012-03-22 |
| EP2616044A1 (en) | 2013-07-24 |
| AU2011303715A1 (en) | 2013-04-04 |
| BR112013005772A2 (pt) | 2019-09-24 |
| KR20140029356A (ko) | 2014-03-10 |
| CA2810598A1 (en) | 2012-03-22 |
| WO2012035283A8 (en) | 2013-08-22 |
| JP2013537182A (ja) | 2013-09-30 |
| US20130315988A1 (en) | 2013-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ602955A (en) | Pharmaceutical composition comprising efavirenz | |
| GB2519913A (en) | Treatment of intracellular bacterial infection | |
| NZ595904A (en) | A novel formulation of meloxicam | |
| IL309564A (en) | Preparations containing apixaban | |
| NZ595987A (en) | A novel formulation of diclofenac | |
| WO2012035283A8 (en) | Pharmaceutical composition | |
| AU2013293116A8 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| TWI347326B (en) | Process for preparation of cationically stabilized and water-redispersible polymer powder compositions | |
| WO2007109244A3 (en) | Novel nanoparticles for delivery of active agents | |
| MY166868A (en) | Bactericidal agent composition | |
| NZ595903A (en) | A novel formulation of metaxalone | |
| MX368346B (es) | Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas. | |
| EP4403172A3 (en) | Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine | |
| EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
| NZ596876A (en) | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | |
| MX2013002660A (es) | Heteroarilmetilamidas. | |
| UA106973C2 (uk) | Пігментні гранули | |
| WO2011106765A3 (en) | Rubber compositions including siliceous fillers | |
| PH12013501846A1 (en) | A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide | |
| CN105532655A (zh) | 无机纳米复合抗菌橡胶乳胶手套液态母料及其制备方法 | |
| CN102993862A (zh) | 一种低voc抗菌环保型乳胶漆及其制备方法 | |
| HUE036121T2 (hu) | Szubmikron kalcium-karbonát részecskéket tartalmazó bevonókészítmény, eljárás ennek elõállítására, valamint a szubmikron kalcium-karbonát részecskék bevonó-készítményekben való alkalmazása | |
| MX366744B (es) | Composición super-hidrofóbica, su preparación y papel que presenta super-hidrofobicidad. | |
| MX2009004557A (es) | Composicion farmaceutica granulada seca y metodos para producirla. | |
| NZ598833A (en) | Antimicrobial and wound-healing action pharmaceutical composition for external application process of producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2016 BY CPA GLOBAL Effective date: 20150703 |
|
| LAPS | Patent lapsed |